Pregnancy-related aortic complications in women with bicuspid aortic valve.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
12 07 2023
Historique:
received: 30 12 2022
accepted: 05 04 2023
medline: 14 7 2023
pubmed: 6 5 2023
entrez: 5 5 2023
Statut: epublish

Résumé

To describe the aortic-related risks associated with pregnancy in women with bicuspid aortic valve (BAV) and to evaluate changes in aortic diameter in pregnancy. Prospective observational study of patients with BAV from a single-site registry of pregnant women with structural heart disease between 2013 and 2020. Cardiac, obstetric and neonatal outcomes were studied. An assessment of aortic dimensions was performed during pregnancy by two-dimensional echocardiography. Aortic diameters were measured at the annulus, root, sinotubular junction and maximum ascending aorta diameter, and the largest diameter was used. Measurements of the aorta were made using the end-diastolic leading edge-to-leading edge convention. Forty-three women (32.9 years, IQR 29.6-35.3) with BAV were included: 9 (20.9%) had repaired aortic coarctation; 23 (53.5%) had moderate or severe aortic valve disease; 5 (11.6%) had a bioprosthetic aortic valve; and 2 (4.7%) had a mechanical prosthetic aortic valve. Twenty (47.0%) were nulliparous. The mean aortic diameter in the first trimester was 38.5 (SD 4.9) mm, and that in the third trimester was 38.4 (SD 4.8) mm. Forty (93.0%) women had an aortic diameter of <45 mm; 3 (7.0%) had 45-50 mm; and none had >50 mm. Three women (6.9%) with BAV presented cardiovascular complications during pregnancy or the postpartum period (two prosthetic thrombosis and one heart failure). No aortic complications were reported. There was a small but significant increase in aortic diameter during pregnancy (third trimester vs first trimester, 0.52 (SD 1.08) mm; p=0.03). Obstetric complications appeared in seven (16.3%) of pregnancies, and there were no maternal deaths. Vaginal non-instrumental delivery was performed in 21 (51.2%) out of 41 cases. There were no neonatal deaths, and the mean newborn weight was 3130 g (95% CI 2652 to 3380). Pregnancy in BAV women had a low rate of cardiac complications with no aortic complications observed in a small study group. Neither aortic dissection nor need for aortic surgery was reported. A low but significant aortic growth was observed during pregnancy. Although requiring follow-up, the risk of aortic complications in pregnant women with BAV and aortic diameters of <45 mm at baseline is low.

Identifiants

pubmed: 37147129
pii: heartjnl-2022-322328
doi: 10.1136/heartjnl-2022-322328
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1153-1158

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: AE is an International Advisory Board Member for BMJ Heart.

Auteurs

Laura Galian-Gay (L)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Antonia Pijuan-Domenech (A)

Adult Congenital Heart Disease Unit, Hospital Vall d'Hebron, Barcelona, Spain tonyapijuan@hotmail.com.

Javier Cantalapiedra-Romero (J)

Integrated Vall d'Hebron - Sant Pau Adult Congenital Heart Disease Unit, Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Berta Serrano (B)

Department of Obstetrics and Gynaecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Maria Goya (M)

Obstetrics, Maternal Fetal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Nerea Maiz (N)

Department of Obstetrics and Gynaecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Manel Casellas (M)

Department of Obstetrics and Gynaecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Susana Manrique (S)

Department of Anesthesiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Elena Suàrez-Edo (E)

Department of Anesthesiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Berta Miranda-Barrio (B)

Adult Congenital Heart Disease Unit, Hospital Vall d'Hebron, Barcelona, Spain.

Blanca Gordon Ramirez (B)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Integrated Vall d'Hebron - Sant Pau Adult Congenital Heart Disease Unit, Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Gisela Teixidó-Turà (G)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Laura Gutierrez-Moreno (L)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Victor González-Fernández (V)

Adult Congenital Heart Disease Unit, Hospital Vall d'Hebron, Barcelona, Spain.

Lydia Dux-Santoy (L)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Andrea Guala (A)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Arturo Evangelista (A)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Laura Dos-Subirà (L)

Adult Congenital Heart Disease Unit, Hospital Vall d'Hebron, Barcelona, Spain.

Jose F Rodriguez-Palomares (JF)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Ignacio Ferreira-Gonzalez (I)

Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH